These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24726695)

  • 21. Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Bamias G; Pizarro TT; Cominelli F
    Inflamm Bowel Dis; 2022 Mar; 28(3):337-349. PubMed ID: 34904152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Features of intestinal lesions in the clinical course of inflammatory bowel diseases.
    Vetuschi A; Latella G; Pompili S; Gaudio E; Sferra R
    Ital J Anat Embryol; 2014; 119(3):286-303. PubMed ID: 26749690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European consensus on the histopathology of inflammatory bowel disease.
    Magro F; Langner C; Driessen A; Ensari A; Geboes K; Mantzaris GJ; Villanacci V; Becheanu G; Borralho Nunes P; Cathomas G; Fries W; Jouret-Mourin A; Mescoli C; de Petris G; Rubio CA; Shepherd NA; Vieth M; Eliakim R; ;
    J Crohns Colitis; 2013 Nov; 7(10):827-51. PubMed ID: 23870728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bowel Location Rather Than Disease Subtype Dominates Transcriptomic Heterogeneity in Pediatric IBD.
    Venkateswaran S; Marigorta UM; Denson LA; Hyams JS; Gibson G; Kugathasan S
    Cell Mol Gastroenterol Hepatol; 2018; 6(4):474-476.e3. PubMed ID: 30364773
    [No Abstract]   [Full Text] [Related]  

  • 26. Biomarkers of Inflammation in Inflammatory Bowel Disease.
    Sands BE
    Gastroenterology; 2015 Oct; 149(5):1275-1285.e2. PubMed ID: 26166315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of tissue remodeling in inflammatory bowel disease.
    Rieder F; Fiocchi C
    Dig Dis; 2013; 31(2):186-93. PubMed ID: 24030223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
    Seo JK; Yeon KM; Chi JG
    J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (II).
    Egan L; D'Inca R; Jess T; Pellino G; Carbonnel F; Bokemeyer B; Harbord M; Nunes P; Van der Woude J; Selvaggi F; Triantafillidis J
    J Crohns Colitis; 2014 Jan; 8(1):19-30. PubMed ID: 23664498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.
    Rieder F; Fiocchi C; Rogler G
    Gastroenterology; 2017 Feb; 152(2):340-350.e6. PubMed ID: 27720839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science.
    Rieder F; Fiocchi C
    Curr Opin Gastroenterol; 2008 Jul; 24(4):462-8. PubMed ID: 18622160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases.
    Roszak D; Gałęcka M; Cichy W; Szachta P
    Adv Med Sci; 2015 Sep; 60(2):246-52. PubMed ID: 25989184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolving intestinal fibrosis through regenerative medicine.
    Schwab R; Lim R; Goldberg R
    Curr Opin Pharmacol; 2019 Dec; 49():90-94. PubMed ID: 31689676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of heat shock protein 47 in intestinal fibrosis of experimental colitis.
    Kitamura H; Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Matsumura K; Takeda Y; Uza N; Nagata K; Chiba T
    Biochem Biophys Res Commun; 2011 Jan; 404(2):599-604. PubMed ID: 21144841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromogranin A and other enteroendocrine markers in inflammatory bowel disease.
    Massironi S; Zilli A; Cavalcoli F; Conte D; Peracchi M
    Neuropeptides; 2016 Aug; 58():127-34. PubMed ID: 26804239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory bowel disease exacerbation associated with Epstein-Barr virus infection.
    Dimitroulia E; Pitiriga VC; Piperaki ET; Spanakis NE; Tsakris A
    Dis Colon Rectum; 2013 Mar; 56(3):322-7. PubMed ID: 23392146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.
    Verstockt B; Noor NM; Marigorta UM; Pavlidis P; Deepak P; Ungaro RC;
    J Crohns Colitis; 2021 Sep; 15(9):1431-1442. PubMed ID: 33730756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Autophagy in the Maintenance of Intestinal Homeostasis.
    Baxt LA; Xavier RJ
    Gastroenterology; 2015 Sep; 149(3):553-62. PubMed ID: 26170139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Natural history of intestinal lesions in inflammatory bowel disease].
    Beaugerie L
    Rev Prat; 2014 Nov; 64(9):1226-9. PubMed ID: 25638859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diet in Intestinal Fibrosis: A Double-Edged Sword.
    Marion-Letellier R; Leboutte M; Amamou A; Raman M; Savoye G; Ghosh S
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.